Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmirtazapine for Vasomotor Symptoms in Menopause
NCT00560833Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of esmirtazapine in vasomotor symptoms, sponsored by Merck & Co.. Started Oct 2004; status: completed.
02
Drugs
esmirtazapine
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT00560833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560833.